Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,249
Total Claims
$859K
Drug Cost
562
Beneficiaries
$1,528
Cost/Patient
Risk Score Breakdown 29/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-74%
Opioid rate vs peers
0.6% vs 2.2% avg
+8%
Cost per patient vs peers
$1,528 vs $1,411 avg
+23%
Brand preference vs peers
13.0% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.6%
Opioid Rate
66
Opioid Claims
$1,297
Opioid Cost
19.7%
Long-Acting Rate
Brand vs Generic
Brand: 1,461 claims · $633K
Generic: 9,739 claims · $222K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 243 | $135K |
| Sitagliptin Phosphate | 85 | $80K |
| Rivaroxaban | 66 | $50K |
| Empagliflozin | 73 | $45K |
| Sitagliptin Phos/Metformin Hcl | 17 | $24K |
| Sitagliptin Phos/Metformin Hcl | 30 | $21K |
| Fluticasone/Vilanterol | 30 | $16K |
| Budesonide/Formoterol Fumarate | 35 | $15K |
| Tiotropium Bromide | 20 | $14K |
| Insulin Detemir | 12 | $13K |
| Dulaglutide | 21 | $12K |
| Tiotropium Bromide | 12 | $11K |
| Mirabegron | 15 | $9,986 |
| Insulin Glargine,hum.Rec.Anlog | 33 | $9,866 |
| Linaclotide | 17 | $9,270 |
Prescribing Profile
Patient Profile
77
Avg Age
51%
Female
1.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About